cidofovir anhydrous has been researched along with Conjunctival Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coroneo, MT; Ip, MH | 1 |
| Coroneo, MT; Ip, MH; Naing, Z; Perlman, EM; Rawlinson, W; Robert George, CR | 1 |
| Farahmand, SM; Feldman, KA; Margolis, TP; Sherman, MD | 1 |
3 other study(ies) available for cidofovir anhydrous and Conjunctival Neoplasms
| Article | Year |
|---|---|
Treatment of Previously Refractory Ocular Surface Squamous Neoplasia With Topical Cidofovir.
Topics: Administration, Ophthalmic; Aged; Carcinoma in Situ; Cidofovir; Conjunctival Neoplasms; Cytosine; Humans; Male; Neoplasm Recurrence, Local; Organophosphonates | 2017 |
Topical Cidofovir for Treatment-Refractory Ocular Surface Squamous Neoplasia.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Conjunctival Neoplasms; Corneal Diseases; Eye Neoplasms; Female; Humans; Male; Ophthalmic Solutions; Retrospective Studies | 2018 |
Treatment of conjunctival squamous cell carcinoma with topical cidofovir.
Topics: Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Cidofovir; Conjunctival Neoplasms; Cytosine; Female; Humans; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds | 2002 |